Novel 2-benzylthio-5-(1,3,4-oxadiazol-2-yl)benzenesulfonamides with anticancer activity: synthesis, QSAR study, and metabolic stability

Jarosław Sławiński , Krzysztof Szafrański , Aneta Pogorzelska , Beata Żołnowska , Anna Kawiak , Katarzyna Macur , Mariusz Belka , Tomasz Bączek

Abstract

n/a
Author Jarosław Sławiński
Jarosław Sławiński,,
-
, Krzysztof Szafrański
Krzysztof Szafrański,,
-
, Aneta Pogorzelska
Aneta Pogorzelska,,
-
, Beata Żołnowska
Beata Żołnowska,,
-
, Anna Kawiak KB - [Medical Uniwersity of Gdańsk (GUMed)]
Anna Kawiak,,
- Department of Biotechnology
- Gdański Uniwersytet Medyczny
, Katarzyna Macur ZLS
Katarzyna Macur,,
- Zespół Laboratoriów Specjalistycznych MWB UG i GUMed
, Mariusz Belka
Mariusz Belka,,
-
, Tomasz Bączek
Tomasz Bączek,,
-
Journal seriesEuropean Journal of Medicinal Chemistry, ISSN 0223-5234
Issue year2017
Vol132
Pages236-248
Publication size in sheets0.6
Keywords in English2-mercaptobenzenesulfonamide, synthesis, 1,3,4-oxadiazole, anticancer activity, QSAR, metabolic stability
DOIDOI:10.1016/j.ejmech.2017.03.039
URL https://doi.org/10.1016/j.ejmech.2017.03.039
Languageen angielski
LicenseJournal (articles only); published final; Other open licence; after publication
Score (nominal)40
ScoreMinisterial score = 40.0, 20-12-2017, ArticleFromJournal
Ministerial score (2013-2016) = 40.0, 20-12-2017, ArticleFromJournal
Publication indicators WoS Impact Factor: 2016 = 4.519 (2) - 2016=4.187 (5)
Citation count*0
Cite
Share Share

Get link to the record
msginfo.png


* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.
Back